Understanding TMC1 to help restore hearing
TMC gene function in sensory hair cells
Researchers are working to understand how TMC1 gene problems cause genetic hearing loss and to develop ways to restore hearing for people with TMC1-related deafness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11226615 on NIH RePORTER |
What this research studies
This project looks at the TMC1 protein that is essential for sensing sound in inner-ear hair cells and studies its structure and function using purified protein and native cells. The team uses mouse models that carry the same TMC1 mutations found in people to see how those changes damage hearing. They are also testing gene-delivery methods, including AAV-based approaches, to try to restore hair cell function in those mice. Results from these lab and animal experiments are intended to guide future therapies for people with TMC1-related hearing loss.
Who could benefit from this research
Good fit: Ideal candidates are people with a confirmed genetic diagnosis implicating TMC1 (such as DFNA36 or DFNB7/B11) and sensorineural hearing loss who might be eligible for future gene-based treatments.
Not a fit: People whose hearing loss is caused by other genes, noise, infection, aging, or non-sensorineural conditions are unlikely to benefit from TMC1-targeted approaches.
Why it matters
Potential benefit: If successful, this work could lead to therapies that restore or improve hearing for people with TMC1-linked genetic hearing loss.
How similar studies have performed: Preclinical work in mice using gene-delivery methods has shown promise in restoring hair cell function, but human testing remains limited.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Holt, Jeffrey R — Boston Children's Hospital
- Study coordinator: Holt, Jeffrey R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.